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1. Introduction 
Implantable pacemakers (P), cardioverter defibrillators (CD), cardiac resynchronization 
systems (CRS), closed-loop recorders, and hemodynamic monitoring implantable products 
offer multiple programmable options, which allow storage of large quantities of diagnostic 
information related to the device’s function. Traditionally, these mechanisms require direct 
interrogation to allow seeing the scheduled parameters and stored data to identify and 
correct possible malfunctioning and improve rescheduling therapy. Implantation of these 
devices (P, CD, and CRS) has been increasing day by day, thus considerably increasing 
patients’ handling and healthcare system work load. To reduce the time that outpatient 
services impose and to optimize patient care, manufacturers of these devices offer 
increasingly more refined remote questioning instruments. Recent technological progresses 
and a better administration of economical resources may probably allow widening of the 
use of remote monitoring in the upcoming years.  
2. Remote monitoring systems 
Currently, there are different monitoring devices and almost all manufacturers have 
introduced their own version of remote monitoring systems (Figure 1); for example, 
Biotronik has introduced the Biotronik Home Monitoring® system; Medtronic® has 
introduced the CareLink® Network; Latitude® Patient Management system has been 
introduced by Boston Scientific®, and St. Jude Medical’s Merlin.net® Patient Care Network 
(PCN). All these equipments can be compared according to their main characteristics (Table 
I), and to be implemented, they need to be equipped with an antenna that communicates to 
a small external device known as transmitter that is able to question the diagnosis 
parameters of the data stored in most of the devices, either with patient’s active 
participation or at pre-scheduled intervals. 
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Parameters 
Biotronik Home 
Monitoring® 
Medtronic 
Carelink® 
Network 
Boston Scientific 
Latitude® 
Merlin.net® 
Patient Care 
Network (PCN) 
FDA’s date of 
approval 
2001 2005 2006 2007 
Device name CardioMessenger®
PatientLook 
SentryCheck 
(OptiVol) 
Latitude 
Communicator 
Merlin@home 
Characteristics Portable Stationary 
Stationary, 
interactive 
Stationary, 
voice-interactive 
Telemetry at 
home USA 
MICS MICS, antenna 
Antenna and 
wireless 
MICS 
Telemetry - 
rest of the 
world 
MICS Antenna Not available Antenna 
Wireless 
products 
All products 
DAI and DAI + 
ResBiv 
All products 
DAI and DAI + 
ResBiv 
Reminders / 
Manual 
transmission 
Automatic No Yes Yes 
Patient takes 
actions in case 
of event 
CardioMessenger®
/ Recall 
Audio Audio Vibration 
Telemetry 
range 
4-GSM band, 
GPRS, mobile, 
analog line 
Analog line Analog line Analog line 
Interaction 
during 
transmission 
No 
No (wireless) 
Yes (Analog line)
No (wireless) 
Yes (Analog line)
No (wireless) 
Yes (Analog 
line) 
Transmission 
Daily, follow-up, 
event messages 
(automatic) 
Scheduled 
follow-up, event 
message (started 
by the patient) 
Scheduled follow-
up, event message 
(started by the 
patient) 
Started by the 
patient (manual) 
Event 
transmission 
route 
Fax, Internet, e-
mail, text message
e-mail, text 
message 
Fax, phone 
Fax, Internet, 
EMR 
Early detection 
<24 hours (all 
events) 
<24 hours 
(certain kind of 
events) 
<24 hours (certain 
kind of events) 
Not available 
Data storage Long term Long term Long term Long term 
EMR interface HL7 HL7, EMR HL7 HL7, EMR 
Data 
presentation 
Event- and 
signaling-based 
Event-based 
Orientation in 
signaling 
Event-based 
Real-time 
EGM 
Event-generated 
Holter and 
pacemaker 
Holter and 
pacemaker 
Not available 
Holter 
transmission 
>45 sec. 10 sec. 10 sec. 30 sec. 
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Parameters 
Biotronik Home 
Monitoring® 
Medtronic 
Carelink® 
Network 
Boston Scientific 
Latitude® 
Merlin.net® 
Patient Care 
Network (PCN) 
Sensor IC monitor 
OptiVol®, 
Cardiac Compass
Weight, BP, 
symptoms, 
pacemaker 
statistics 
Statistics and 
surface ECG 
Repercussion 
on long-lasting 
battery 
Low High High Not available 
Abbreviations: MICS = Medical implant and Communications bandwidth (402-405 MHz), GSM = 
Global System for Mobile Communication, GPRS = General Packet Radio Service, HL7 = Interface 
standard, EMR = Electronic medical records, EGM = intracavitary electrocardiogram, IC = Heart failure, 
DAI = Implantable automatic defibrillator, DAI + ResBiv = Implantable automatic defibrillator plus 
biventricular resynchronizer 
Table 1. Remote monitoring systems 
 
 
Fig. 1. The four remote monitoring systems currently in use. 
Once captured, the data from that device are uploaded using a transmitter that has a 
standard analogical telephone line or wireless telephones, to a safe central where the data 
are processed. The patient receives messages or event alerts through an acoustic signal (beep) 
and/or vibrations, and in certain systems, such alerts are used to indicate that the patient 
should start the data manual transfer from the transmitter to a central base. During 
transmission, the level of participation varies depending on the manufacturers’ and the 
patient’s clinical condition, and the urgency of the processed data may trigger a rapid alert 
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to the physician through an email, text messages, fax, or a phone call, in which a detailed 
report is simultaneously published in a secure website for the visualization of the physician 
or another authorized reviewer. 
Most of the remote monitoring systems transmit patients’ data through standard telephone 
lines, either on a weekly or fortnightly basis. Yet, we should not forget that there are other 
equipments, such as Biotronik Home Monitoring®, in which the transmission is based on a 
wireless telephone that could be carried in the belt or handbag, which is capable of 
capturing the stored information daily. Still, with either system, the patient’s information 
can be continuously controlled and the variables that are included more frequently are 
battery status, battery impedance, electrode impedance, post-shock impedance, arrhythmia 
detection, therapies administered, and average heart rate. Furthermore, it is possible to 
record an electrogram (EGM) of the event that triggered the alert or, failing this, a change in 
the electrode impedance, caused by a fracture or the device elective replacement, as well as 
inefficiency to deliver a stimulus, onset of atrial fibrillation (AF) events, and heart failure 
(HF) deterioration. 
Typically, transmission parameters differ among equipments; nevertheless, they are 
adjustable to each patient. The physician can set specific alert conditions according to the 
patient’s base disease. Remote monitoring reports are generated and sent with different alert 
levels, so that the individual may answer according to their urgency. For instance, the 
physician could be notified within an hour (if so scheduled) in case of ventricular 
tachycardia or increase in ventricular extrasistolia: two events that trigger an alert of 
different levels. The main differences among the remote monitoring procedures relate to the 
data transmission frequency and reporting, the necessary level of patient participation for 
the transmission success, and the movement capability that they offer. No system allows the 
programming remote control a functionality that probably will not be available soon 
because of ruling issues and the legal medical rate. 
3. Types of remote monitoring systems 
The Biotronik Home Monitoring® system transmits data on a daily basis, at fixed intervals 
and soon after a clinically relevant event has occurred. Home Monitoring® has introduced 
the first equipment of this kind in 2001 and it is currently available in over 50 countries. The 
equipment can be programmed per event line and individual surveillance parameters. The 
usual events included in these devices are atrial monitoring for AF detection, HF 
monitoring, and high-definition intracavitary EGM (Figure 2), similar to the therapies being 
administered. 
This system bases its functioning in three steps: The first step is the communication between 
the implanted generator and the patient device, named CardioMessenger (CM) (Figure 3). 
The generator emits a message at a medical implant-reserved frequency (402–405 MHz) to 
the CM, activating a radiofrequency (RF) circuit integrated to the head of the implanted 
equipment. On the scheduled time, the patient must be from 20 cm to 2 m far from the CM 
to ensure successful transmission. 
The second step relates to the CM message delivery to the service central in Germany, via 
GSM/GPRS cellular. The CM zips and codes the information using the standard known as 
Digital Encryption Standard (DES), owing to which the patient can be elsewhere in the 
world with access to a cellular network, and the system will function normally (Figure 4).  
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Fig. 2. An intracavitary ECG of a resynchronizer with implantable automatic defibrillator, 
which was sent as a device periodical report of the Biotronik Home Monitoring® system, 
available in the Internet. The mark channel can be observed at the top and the 
electrocardiograms can be found at the bottom.  Abbreviations: Ap = Stimulation of the 
right atrium. Vp = Stimulus of the right ventricle. VIp = Stimulus of the left ventricle. A = 
EGM of the right atrium. VD = EGM of the right ventricle. VI = EGM of the left ventricle. 
 
 
 
Fig. 3. Three types of CardioMessenger® of Biotronik Home Monitoring® system. 
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Fig. 4. Chart showing for whom the Biotronik Home Monitoring® system works. The 
approximate transmission time is of about 5 minutes. 
This is an automatic system performing the following types of transmissions and messages: 
1. Every 24 hours, at a physician-preset time, the device sends a transmission containing the 
data gathered along the last 24 hours and the CM issues a message to the service center. 
2. When any major cardiac event or change occurs in the device’s or electrodes’ technical 
parameters, a message is immediately sent. 
In the third step, the physician receives a report issued from the service center based in 
Germany, named CardioReport, to which he/she will have access through an internet-based 
secure webpage (Figure 5). He/she may also receive a text message (SMS), fax, or e-mail 
informing him/her that the patient must be monitored in case of an adverse event. In the 
internet, the physician will have access, from any computer, to  whole information related to 
the event and/or report, and to the device and its electrodes, which will have the following 
characteristics: 
• Home page: Intuitive platform that allows the physician to rapidly visualize patients 
who need more attention. 
• Consolidated report (CardioReport) per patient, continuously updated. 
• Control and recognition of changed events and the possibility to recognize alert 
changes. 
• Fields to add comments and remarks, which relate to both the patient and his/her 
clinical history. 
• Time line: history of detailed events on a time line. 
The system rapidly transmits symptomatic or asymptomatic events, regardless of the 
patient’s location, in that it is automatic, silent, and does not require his/her participation. 
The follow-up can be either monthly, quarterly, or half-yearly, and the physician may also 
access the accumulated files published in an internet-secure site for rapid review and 
evaluation of its evolution. 
The CareLink®Network (Medtronic®) system is designed to perform remote monitoring of 
the status of the implanted device and includes a monitor and an antenna, through which 
the patient and/or the medical personnel may interact. 
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Fig. 5. Page available at the Biotronik Home Monitoring® website portal in which the 
patients’ conditions can be observed. Red and yellow colors, characteristics of the signaling, 
according to the level of attention that should be addressed; in this case, yellow color 
indicates review and red signifies urgent review. 
The monitor is small and has an antenna that connects to an analogical telephone line. The 
user (who may be the patient him/herself) has to press a button to switch it on and place the 
antenna onto the implanted device. The monitor questions and transmits the patient’s 
technical and physiologic data stored in it and 10 seconds, in real time, of the EGM. 
The monitor will automatically call a toll-free telephone number and send the information to 
the servers of the CareLink® system using a safe connection. To inform the patient that the 
transmission has successfully occurred, the monitor uses audible tones and visual indicators. 
There are two types of monitors, manuals and automatics, which work in a similar way, 
even with some small differences. CareLink® monitors operate with a single specific 
implantable device, i.e. each monitor is linked to the serial number of the implanted 
equipment and will not work in another patient, because the server will not accept 
transmissions made from a CareLink® monitor associated with another device. There is a 
webpage where it is possible to visualize the condition of the discharged patients using a PC 
with Internet through a web browser (Figure 6), and only registered personnel will have 
access to the data of the patients followed up in that center. 
The in-line format allows a detailed report, in which it counts on a Cardiac Compass® 
visualization system that allows visualization of up to 14 months of accumulated 
parameters, namely, atrial and ventricular stimulation, heart rate, atrial fibrillation events, 
and the response of the heart rate to the patient’s activity. The CareLink®Network 
(Medtronic®) system includes in its follow-up those devices available in OptiVol®, a single 
sensor for the increase in the pulmonary fluid used for the early detection of deterioration of 
HF. This sensor indicates the ratio between the liquid status and the intrathoracic 
impedance, and the system is driven through a device-issued audible tone, which asks the 
patient to start a period of communication sessions in response to the events that the 
implanted device has detected, as well as relevant clinical changes in the system: 
arrhythmias, administered therapies, etc. The description customization for each patient 
requires the use of a programmer during the outpatient visit. Manual programming also 
needs to define the transmission. 
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Fig. 6. Webpage of the CareLink® Network (Medtronic®) system in which a list of patients, 
type of alert under the signaling scheme, and type of event, battery voltage, and type of 
device can be observed. 
Latitude® Patient Management System (Boston Scientific®) admits almost all Boston 
Scientific® devices, namely CD and RCS, depending on the implanted device and on the 
fact that it is operated through telemetry or a wireless transmitter to question the device at 
home, usually on a weekly basis. The transmitter also uses a ground analogical system to 
transmit data that can be configured to be used in several countries. A unique characteristic 
of this product is the possibility to wirelessly connect weight and blood pressure scales for 
the remote monitoring of the HF condition; also in addition, the patient may obtain an 
automatic weekly report of his/her condition (fatigue, ankle edema, orthopnea, etc.). 
Notices of events may be individually configured based on the “red” and “yellow” alerts. 
Furthermore, the customized data transmission system allows different physicians (general 
physician, cardiologist, and electrophysiologist) to improve the follow-up in HF clinics.  
St. Jude Medical’s Merlin.net® Patient Care Network (PCN) is an implant procedure and 
implantable device clinical follow-up remote transmission system that stores data for up to 7 
years. The implant system is provided through InvisiLink® Wireless telemetry and the 
follow-up is provided through the RF Merlin@home® transmitter, which receives the 
DirectCall® messages; furthermore, it offers an online agenda. A useful characteristic is the 
possibility offered to the physician to indicate warnings and regular remainders for medical 
appointments in the patient’s transmitter and to make automatic calls to patients with the 
results. The monitoring system sends daily notices known as DirectAlerts® and can export a 
database by integrating the Healthcare Enterprise (IHE) system. The Merlin@home® system 
is a small box, similar to a phone operating in the medical device band in the 402–405 MHz 
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range. It has a start button that allows the interrogation to be started by the patient, and has 
status lights for both the transmitter and the transmission in one icon and connects to an 
analogical telephone line. On a daily basis, it checks the status of the implanted device and 
notification is sent to the physician through e-mail, fax, text message, phone call, or Internet 
(Figure 7). The device may be used in emergency rooms. In addition, there is a version that 
is not wireless. The system has both manual and automatic programming; pool 
programming is possible and it also offers DirectCall® message feature; notifications 
(DirectAlert®) that allow the patient’s condition to be monitored may be configured either 
as urgent or report. It has a DirectTrend™ visualization that graphically shows the 
stimulation percentage trend. 
 
 
Fig. 7. Webpage of the Merlin.net® Patient Care Network (PCN) system in which the list of 
patients, type of devices, and other characteristics can be observed. 
4. Benefits of remote monitoring 
The Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) 
have defined that the main purpose of remote monitoring is to identify the device’s 
abnormal behavior as soon as possible to limit the sub-registration of its malfunctioning. 
This is how they have also established the determining factors to set the device follow-up 
frequency; something of utmost importance was to establish the minimum interval required 
to provide follow-up, either on-site or remotely (Table II). 
Currently, the Biotronik Home Monitoring® seems to be the best system for the early 
detection of the abnormal behavior of the device. This may be particularly pertinent in the 
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Conditions Type of monitoring 
Within the first 72 hours after having 
implanted a P,CD, CRS 
Personally 
Two to twelve weeks after having implanted a 
P,CD, CRS 
Personally 
Three to twelve months after having implanted 
a P, CRS 
Personally or remotely 
Three to twelve months after having implanted 
a CRS + defibrillator and CD 
Personally or remotely 
Annually, until the battery voltage reduction Personally 
Monthly, until three months, with data related 
to the battery voltage reduction 
Personally or remotely 
Abbreviations: P = Pacemaker, CD = Cardioverter defibrillator, CRS = Cardiac resynchronization 
system 
Table 2. Minimum follow-up time required for remote monitoring or onsite visit of P, CD, 
and CRS 
case of warning-programmed equipment; the daily control of the device may allow the 
expecting behavior without needing to shorten the follow-up intervals, which reduces the 
patient’s anxiety. The reported adverse events include, among others, the imminent 
dysfunction caused by battery worn-out, electrode defects, and inefficient shocks. Some 
similar remarks with other remote monitoring systems suggest a potential of similar output, 
even if with lower risk of early detection.  
Another important target of remote monitoring is the reduction in the number of followed-
up patients attending the hospital. Remote monitoring could become a tool that, maybe, 
could replace visits to the hospital, which may be unnecessary when remote monitoring has 
not detected any issues. It has to be mentioned that nowadays the remote monitoring 
systems have improved the data capture format as well as alert-reporting, which is partially 
user-defined, and simplification of their interpretation, what has enhanced the time 
scheduled for its analysis. 
Remote monitoring can also has a positive impact on the quality of the medical service and 
the patient’s quality of life, because: 
• It allows the early detection of arrhythmias, changes in the device functioning, or 
changes in the patient condition during follow-up. 
• It helps in providing individual programming time aimed to optimize the handling of 
patients having frequent arrhythmias or technical complications, cost reduction, and 
workloads imposed by the patients having no complications or having stable clinical 
conditions. 
• The acceptance of patients to the state-of-the-art reliability that the implanted device 
operates properly, along with the advantage of reduced number of hospital visits. 
Even if more exact indicators of the patient’s clinical conditions have not been clearly 
defined, abnormal vitals, including inadequate increase in the heart rate at rest, minute 
ventilation, and a drop in intrathoracic impedance may be signals of HF deterioration. As 
adaptation to new technologies requires efforts to abandon what is already known, both 
hospital services and physicians are enthusiastically accepting this system. 
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5. Future perspectives 
Remote monitoring may probably be included in the upcoming devices (P, CD, and CRS), 
and one can expect that new useful sensors will be made available soon. These progresses 
may introduce changes in the follow-up procedures and their goals, may allow the 
physicians to opportunely intervene to improve the clinical outcomes, and may cause 
reduction in medical expenses. New sensors may become necessary to prevent HF, as 
measure of intrathoracic impedance, intracardiac pressure, and minute ventilation. Other 
sensors that are potentially valuable for remote monitoring are function of the left ventricle, 
volume of the left ventricle and contractibility, oxygen venous saturation, muscular activity, 
and, finally, myocardium ischemia. The latter is related to recent publications in which one 
may obtain the reconstruction of a 12-derivation ECG through the implanted device (CRS, 
CD), obtaining a good correlation with the conventional surface ECG7. If we aggregate the 
possibility to obtain information through remote monitoring, its utility will be very helpful 
to discriminate myocardium ischemia, atrial and ventricle extrasistolia, and, most 
importantly, the possibility to distinguish between supraventricular tachycardia and 
ventricular tachycardia. Some of these sensors could be used in patients already implanted 
with P, CD, and CRS. 
6. Conclusions 
The remote monitoring system is a useful tool that can be used in health institutions to 
follow-up P, CD, and CRS, obtaining substantial benefits such as early diagnosis of 
arrhythmias, to adequately recommend a treatment. Reduction in the number of visits to 
device clinics allows the patient to freely perform his/her daily activities or travel, because 
he/she will be covered by continuous remote monitoring. Furthermore, there is the 
possibility that patients with any kind of limitation to attend the clinic, either because of any 
physical or transportation limitation, may find an alternative in this system. Finally, with 
remote monitoring, patients counting on any medical alert of recall could benefit from a 
stricter follow-up to detect possible system failures. With all these benefits, the satellite 
remote monitoring system offers an alternative to the on-site visit for the monitoring of the 
devices, though this may not replace medical visit. 
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